Sodium Sulfacetamide 10% and Sulfur 5% Cleanser

Manufacturer
Oncor Pharmaceuticals
Effective date
2026-03-22
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
5
Source
full-release
Hydrated at
2026-05-31 22:10:51

Label at a glance#

ProductSodium Sulfacetamide 10% and Sulfur 5% Cleanser
Active ingredientSULFACETAMIDE SODIUM, SULFUR
Label structure18 sections

Dosage and administration

Wash affected areas once or twice daily, or as directed by your physician. Avoid contact with eyes or mucous membranes. Wet skin and libera ly apply to areas to be cleansed, massage gently into skin for 10-20 seconds working into a full lather, rinse thoroughly and pat dry. If drying occurs, it may be contro led by rinsing cleanser off sooner or using less often.

Storage and handling

Store at 20°C to 25°C (68°F to 77°F). See USP controlled room temperature. Protect from freezing.

Label contents#

Full prescribing information#

Rx OnlyDESCRIPTION

DESCRIPTION SECTION

Each gram of sodium sulfacetamide 10% and sulfur 5% cleanser contains 100 mg of sodium sulfacetamide and 50 mg of sulfur in a cleanser containing Aloe vera leaf extract, Butylated hydroxytoluene, Cetyl alcohol, Citric acid, Cocamidopropyl betaine, Disodium EDTA, Glycerin, Glyceryl stearate SE, PEG-100 stearate, Phenoxyethanol, Purified water, Sodium laureth sulfate, Sodium thiosulfate, Stearyl alcohol, Triacetin, Xanthan gum.

Sodium sulfacetamide is a sulfonamide with antibacterial activity while sulfur acts as a keratolytic agent. Chemically sodium sulfacetamide is N-[(4-aminophenyl)sulfonyl]-acetamide, monosodium salt, monohydrate. The structural formula is:

structurestructure

INDICATIONS

INDICATIONS & USAGE SECTION

Sodium Sulfacetamide 10% & Sulfur 5% Cleanser is indicated in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis.

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

Wash affected areas once or twice daily, or as directed by your physician. Avoid contact with eyes or mucous membranes. Wet skin and libera ly apply to areas to be cleansed, massage gently into skin for 10-20 seconds working into a full lather, rinse thoroughly and pat dry. If drying occurs, it may be contro led by rinsing cleanser off sooner or using less often.

CAUTION

PRECAUTIONS SECTION

If redness or irritaiton occurs, discontinue use.
Call your doctor for medical advice about side effects.

FOR EXTERNAL USE ONLY. NOT FOR INTRA VAGINAL OR OPHTHALMIC USE. (KEEP AWAY FROM EYES).

KEEP OUT OF REACH OF CHILDREN.
Shake well before use

STORAGE

STORAGE AND HANDLING SECTION

Store at 20°C to 25°C (68°F to 77°F). See USP controlled room temperature.

Protect from freezing.

CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY SECTION

The most widely accepted mechanism of action of sulfonamides is the woods-fields theory which is based on the fact that sulfonamides act as competitive antagonists to para-aminobenzoic acid (PABA), an essential component for bacterial growth. While absorption through intact skin has not been determined, sodium sulfacetamide is readily absorbed from the gastrointestinal tract when taken orally and excreted in the urine, largely unchanged. The biological half-life has variously been reported as 7 to 12.8 hours. The exact mode of action of sulfur in the treatment of acne is unknown but it has been reported that it inhibits the growth of propionibacterium acnes and the formation of free fatty acids.

CONTRAINDICATIONS

CONTRAINDICATIONS SECTION

Sodium Sulfacetamide 10% & Sulfur 5% Cleanser is contraindicated for use by patients having known hypersensitivity to sulfonamides, sulfur or any other component of this preparation. Sodium Sulfacetamide 10% & Sulfur 5% Cleanser is not to be used by patients with kidney disease.

WARNINGS

WARNINGS SECTION

Although it is rare, sensitivity to sodium sulfacetamide may occur.

Therefore, caution and careful supervision should be observed when prescribing this drug for patients who may be prone to hypersensitivity to topical sulfonamides. Systemic toxic reactions such as agranulocytosis, acute hemolytic anemia, purpura hemorrhagica, drug fever, jaundice, and contact dermatitis indicate hypersensitivity to sulfonamides. Particular caution should be employed if areas of denuded or abraded skin are involved.

PRECAUTIONSGENERAL

GENERAL PRECAUTIONS SECTION

If irritation develops, use of the product should be discontinued and appropriate therapy instituted. Patients should be carefully observed for possible local irritation or sensitization during long-term therapy. The object of this therapy is to achieve desquamation without irritation, but sodium sulfacetamide and sulfur can cause reddening and scaling of the epidermis. These side effects are not unusual in the treatment of acne vulgaris, but patients should be cautioned about the possibility.

INFORMATION FOR PATIENTS

INFORMATION FOR PATIENTS SECTION

Avoid contact with eyes, eyelids, lips and mucous membranes. If accidental contact occurs, rinse with water. If excessive irritation develops, discontinue use and consult your physician.

CARCINOGENESIS, MUTAGENESIS AND IMPAIRMENT OF FERTILITY

CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY SECTION

Long-term studies in animals have not been performed to evaluate carcinogenic potential.

PREGNANCYCategory C

PREGNANCY SECTION

Animal reproduction studies have not been conducted with Sodium Sulfacetamide 10% & Sulfur 5% Cleanser. It is also not known whether Sodium Sulfacetamide 10% & Sulfur 5% Cleanser can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Sodium Sulfacetamide 10% & Sulfur 5% Cleanser should be given to a pregnant woman only if clearly needed.

NURSING MOTHERS

NURSING MOTHERS SECTION

It is not known whether sodium sulfacetamide is excreted in the human milk following topical use of Sodium Sulfacetamide 10% & Sulfur 5% Cleanser. However, small amounts of orally administered sulfonamides have milk. In view of this and because many drugs are excreted in human milk, caution should be exercised when Sodium Sulfacetamide 10% & Sulfur 5% Cleanser is administered to a nursing woman.

PEDIATRIC USE

PEDIATRIC USE SECTION

Safety and effectiveness in children under the age of 12 have not been established.

undefined

ADVERSE REACTIONS SECTION

Although rare, sodium sulfacetamide may cause local irritation.

HOW SUPPLIED

HOW SUPPLIED SECTION

Sodium Sulfacetamide 10% & Sulfur 5% Cleanser is available in
6 oz (170 g) bottle NDC 83720-547-06
12 oz (340 g) bottle NDC 83720-547-12

SPL UNCLASSIFIED SECTION

In case of accidental ingestion contact a Poison Control Center immediately. Keep container tightly closed.

You may report side effects by ca ling Oncor Pharmaceuticals (9 a.m. to 5 p.m. EST), at 1-443-876-7600 or FDA at 1-800-FDA-1088.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Manufactured In USA For :

Oncor Pharmaceuticals
6755 Business Pkwy Suite 202
Elkridge, MD 21075
United States.
Rev. 08/25

6 oz label6 oz label

12 oz label12 oz label

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
999613sulfacetamide sodium 10 % / sulfur 5 % Medicated Liquid SoapPSN5
999613sulfacetamide sodium 100 MG/ML / sulfur 50 MG/ML Medicated Liquid SoapSCD5
999613sulfacetamide sodium 10 % / sulfur 5 % Medicated Liquid SoapSY5
999613sulfacetamide sodium 10 % / sulfur 5 % Topical CleanserSY5

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
SULFACETAMIDE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
4073022c-5d5d-48f5-82ed-091ad146a4b2Product name120171211
9ffbd0ae-0bce-c086-b707-f0da5f8cd7c5Product name120150828
0304b7d2-7a07-d53b-750f-36012ae6612eProduct name120140508
64c0cc7e-6478-3ca1-8cd7-9a1251d5a3f6Product name120140508
9ae74339-0a3d-82e9-5dd1-88bd2607bd6bProduct name120140508
e44e38a9-2d9e-b0e2-cce9-490554639f3dProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
83720-547-06Sodium Sulfacetamide 10% and Sulfur 5% Cleanser170 g in 1 BOTTLE, PLASTICRINSE1705
83720-547-12Sodium Sulfacetamide 10% and Sulfur 5% Cleanser340 g in 1 BOTTLE, PLASTICRINSE3405

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
83720-547-06GM - Gram83720-5477f364f89-dd9b-4199-a35e-5dfd2d3a5afb12025-09-12
83720-547-12GM - Gram83720-547669a26e2-65d1-4f65-b9c3-cc304ce538e512025-09-12

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 21 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
83720-54783720-547-06, 83720-547-12

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 18 matching rows.

Source Document#

Source XML

Older Hydrated Versions#

Version, Effective date, Source table
VersionEffective dateSourceHydrated
42026-02-11monthly-update2026-06-03 17:57:28
32025-11-05monthly-update2026-06-03 17:42:21
12025-08-14full-release2026-05-31 21:40:21

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Sodium Sulfacetamide 10% and Sulfur 5% CleanserSODIUM SULFACETAMIDE 10% AND SULFUR 5%Oncor Pharmaceuticalsf5fecb2b-52d7-4373-b432-ad23aa93085e2026-03-22Warnings, Adverse reactionsExact identifier
ndc (package): 83720-547-06
ndc (package): 83720-547-12
ndc (product): 83720-547
ndc11 (package): 83720054712
ndc11 (package): 83720054706
spl id: 4da2ef14-910e-c695-e063-6394a90a9079
spl set id: f5fecb2b-52d7-4373-b432-ad23aa93085e

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.